Chesterford Research Park appoint Dodson Jones as new commercial agents

March 18, 2012 - PRLog -- The joint developers of Chesterford Research Park, Aviva Investors and The Churchmanor Estates Company plc are delighted to announce the appointment of Dodson Jones as commercial agents for Chesterford Research Park.  

Dodson Jones an established Cambridge based property consultancy is led by Michael Jones and Edward Dodson, both of whom have a proven track record of providing expert advice within the Cambridge Commercial market over the last 25 years.

Martin Sylvester, Director of The Churchmanor Estates Company plc commented of the appointment: “We are extremely pleased with the appointment of Dodson Jones to the team at Chesterford.  With the new Science Village development due for completion in May we have a unique opportunity to offer additional biotech and R&D companies space at the Park in 2012.  We are looking forward to working in collaboration with the team at Dodson Jones to continue to raise awareness of both the occupancy options available within Science Village as well as the wider Park environment.  Working together we look forward to welcoming the next generation of tenants to the Park.”

The Science Village development is a multi-million pound speculative development, which will provide 28,000 sq ft of highly flexible, energy efficient, state-of-the-art R&D laboratory and office space.  Designed to encourage occupancy by up to sixteen biotechnology and next generation R&D companies with their associated economic opportunities, the Science Village building will be a big draw to local companies and those seeking to locate within the South Cambridge biotech cluster.

Michael Jones, Principal at Dodson Jones, said: "We are delighted to be involved with Chesterford Research Park at this incredibly exciting time.  Both the Science Village development and other opportunities currently available at the Park offer significant flexibility and opportunity for companies wishing to locate within the South Cambridgeshire Biotech cluster.  The overall Park environment provides exceptional scientific facilities coupled with well-executed space for meetings, conferences, relaxation and leisure which is available to all tenants – a very strong combination that will be very attractive to prospective tenants.”

Chesterford Research Park (visit http://www.chesterfordresearchpark.com) provides a unique range of facilities and an excellent working environment for some of the more established pioneers in R&D such as Illumina and Biofocus, as well as the innovative newer breed of biotechnology companies such as Cellzome and Isogenica.  Impressive Park facilities, which include meeting and conferencing space, a restaurant and fully equipped gym within The Nucleus building complement the state-of-the-art R&D and laboratory space available at the Park.  

Chesterford Research Park is ideally situated within easy reach of the City of Cambridge, Stansted airport and the M11.  The Park also operates a taxi service and regular shuttle buses to and from the railway station at Audley End, from which London is only an hour away.  From its position within the South Cambridge Biotech Cluster, Chesterford Research Park is perfectly positioned to offer companies of all sizes attractively located, state-of-the-art facilities.

# # #

Chesterford Research Park is being developed as a 250 acre low density scheme to provide high quality accommodation in an attractive environment for science and technology based companies of all sizes. To date, more than 240,000 sq ft of laboratory and R&D space has been let and occupied. Further phases of construction will extend the development to approximately 600,000 sq ft (56,500 sq m). The park is being developed as a joint venture between Aviva Investors and The Churchmanor Estates Company Plc. http://www.chesterfordresearchpark.com and http://www.thenucleus.uk.com